Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting.
Saved in:
| Title: | Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting. |
|---|---|
| Authors: | Zervanos, Damianos-Ioannis1 (AUTHOR), Galatou, Eleftheria2 (AUTHOR), Miliotou, Androulla N.1,2 (AUTHOR), Theodoroula, Nikoleta F.1,2 (AUTHOR), Grigoriadis, Nikolaos1 (AUTHOR), Vizirianakis, Ioannis S.1,2 (AUTHOR) |
| Source: | Future Pharmacology. Sep2025, Vol. 5 Issue 3, p43. 42p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 188351326 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Zervanos%2C+Damianos-Ioannis%22">Zervanos, Damianos-Ioannis</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Galatou%2C+Eleftheria%22">Galatou, Eleftheria</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Miliotou%2C+Androulla+N%2E%22">Miliotou, Androulla N.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Theodoroula%2C+Nikoleta+F%2E%22">Theodoroula, Nikoleta F.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grigoriadis%2C+Nikolaos%22">Grigoriadis, Nikolaos</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vizirianakis%2C+Ioannis+S%2E%22">Vizirianakis, Ioannis S.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Future+Pharmacology%22">Future Pharmacology</searchLink>. Sep2025, Vol. 5 Issue 3, p43. 42p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=188351326 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/futurepharmacol5030043 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 42 StartPage: 43 Titles: – TitleFull: Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zervanos, Damianos-Ioannis – PersonEntity: Name: NameFull: Galatou, Eleftheria – PersonEntity: Name: NameFull: Miliotou, Androulla N. – PersonEntity: Name: NameFull: Theodoroula, Nikoleta F. – PersonEntity: Name: NameFull: Grigoriadis, Nikolaos – PersonEntity: Name: NameFull: Vizirianakis, Ioannis S. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: Sep2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 26739879 Numbering: – Type: volume Value: 5 – Type: issue Value: 3 Titles: – TitleFull: Future Pharmacology Type: main |
| ResultId | 1 |